{"id":5481,"date":"2022-05-17T07:30:46","date_gmt":"2022-05-17T11:30:46","guid":{"rendered":"https:\/\/bridge-bio.local\/news\/auto-draft\/"},"modified":"2022-12-02T14:09:40","modified_gmt":"2022-12-02T19:09:40","slug":"5481-2","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/5481-2\/","title":{"rendered":"BridgeBio Pharma to Participate in May Investor Events"},"content":{"rendered":"<p><strong>PALO ALTO, CA \u2013 May 17, 2022 \u2014\u00a0<\/strong>BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:<\/p>\n<ul>\n<li><strong>Citi Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Panel, Virtual<\/strong>: Wednesday, May 18<sup>th<\/sup> at 2:30 pm ET<\/li>\n<li><strong> C. Wainwright Global Investment Conference, Virtual: <\/strong>Tuesday, May 24<sup>th<\/sup> at 7:00 am ET<\/li>\n<li><strong>UBS Global Healthcare Conference, New York, NY<\/strong>: Tuesday, May 24<sup>th<\/sup> at 11:30 am ET<\/li>\n<li><strong>J. P. Morgan West Coast Investor Day, San Francisco, CA:<\/strong> Tuesday, May 24<sup>th<\/sup> at 12:00 pm ET<\/li>\n<\/ul>\n<p>To access more details on BridgeBio\u2019s presentations, please visit the \u201cEvents &amp; Presentations\u201d page within the Investors section of the BridgeBio website at <a href=\"https:\/\/investor.bridgebiodev.wpengine.com\/\">https:\/\/investor.bridgebiodev.wpengine.com<\/a>.<\/p>\n<p><strong>About BridgeBio Pharma, Inc.<\/strong><\/p>\n<p>BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio\u2019s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit <a href=\"http:\/\/bridgebio.com\/\"><strong>bridgebiodev.wpengine.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.linkedin.com\/company\/bridgebio\/\"><strong>LinkedIn<\/strong><\/a> and <a href=\"https:\/\/twitter.com\/BridgeBioPharma\"><strong>Twitter<\/strong><\/a>.<\/p>\n<p><strong>BridgeBio Contact:<\/strong><br \/>\nGrace Rauh<br \/>\n<a href=\"mailto:Grace.rauh@bridgebiodev.wpengine.com\"><strong>Grace.rauh@bridgebiodev.wpengine.com<\/strong><\/a><br \/>\n(917) 232-5478<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, CA \u2013 May 17, 2022 \u2014\u00a0BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences: Citi Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Panel, Virtual: Wednesday, May 18th at 2:30 pm [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-5481","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":{"people":false,"external_link":"","presentation":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BridgeBio Pharma to Participate in May Investor Events - BridgeBio<\/title>\n<meta name=\"description\" content=\"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/5481-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio Pharma to Participate in May Investor Events - BridgeBio\" \/>\n<meta property=\"og:description\" content=\"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/5481-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-17T11:30:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-02T19:09:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cybele Gouverneur\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cybele Gouverneur\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/5481-2\/\",\"url\":\"https:\/\/bridgebio.com\/news\/5481-2\/\",\"name\":\"BridgeBio Pharma to Participate in May Investor Events - BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2022-05-17T11:30:46+00:00\",\"dateModified\":\"2022-12-02T19:09:40+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7\"},\"description\":\"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/5481-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/5481-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/5481-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma to Participate in May Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7\",\"name\":\"Cybele Gouverneur\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g\",\"caption\":\"Cybele Gouverneur\"},\"url\":\"https:\/\/bridgebio.com\/author\/cybele-gouverneur\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio Pharma to Participate in May Investor Events - BridgeBio","description":"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/5481-2\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio Pharma to Participate in May Investor Events - BridgeBio","og_description":"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.","og_url":"https:\/\/bridgebio.com\/news\/5481-2\/","og_site_name":"BridgeBio","article_published_time":"2022-05-17T11:30:46+00:00","article_modified_time":"2022-12-02T19:09:40+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Cybele Gouverneur","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Cybele Gouverneur","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/5481-2\/","url":"https:\/\/bridgebio.com\/news\/5481-2\/","name":"BridgeBio Pharma to Participate in May Investor Events - BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2022-05-17T11:30:46+00:00","dateModified":"2022-12-02T19:09:40+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7"},"description":"BridgeBio Pharma announced that members of the management team will participate in four upcoming investor conferences. Learn more.","breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/5481-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/5481-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/5481-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma to Participate in May Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/0ccd4f21aad52916b60d0206bb498df7","name":"Cybele Gouverneur","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1310df87abb2898678c7deb92afe7bc4?s=96&d=mm&r=g","caption":"Cybele Gouverneur"},"url":"https:\/\/bridgebio.com\/author\/cybele-gouverneur\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/5481"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=5481"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/5481\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=5481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=5481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=5481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}